Is Pulmonary Medication Adherence affected by disease severity among adult patients with Cystic Fibrosis?

E. Hatziagorou (Thessaloniki, Greece), K. Manika (Thessaloniki, Greece), S. Kyrvasili (Thessaloniki, Greece), E. Kouroukli (Thessaloniki, Greece), E. Sourla (Thessaloniki, Greece), I. Lialias (Thessaloniki, Greece), S. Kotoulas (Thessaloniki, Greece), M. Sionidou (Thessaloniki, Greece), J. Kioumis (Thessaloniki, Greece), J. Tsanakas (Thessaloniki, Greece)

Source: Virtual Congress 2020 – Clinical monitoring and new therapies for cystic fibrosis
Session: Clinical monitoring and new therapies for cystic fibrosis
Session type: E-poster session
Number: 368

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Hatziagorou (Thessaloniki, Greece), K. Manika (Thessaloniki, Greece), S. Kyrvasili (Thessaloniki, Greece), E. Kouroukli (Thessaloniki, Greece), E. Sourla (Thessaloniki, Greece), I. Lialias (Thessaloniki, Greece), S. Kotoulas (Thessaloniki, Greece), M. Sionidou (Thessaloniki, Greece), J. Kioumis (Thessaloniki, Greece), J. Tsanakas (Thessaloniki, Greece). Is Pulmonary Medication Adherence affected by disease severity among adult patients with Cystic Fibrosis?. 368

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Impact of depression on patients with Idiopathic Pulmonary Fibrosis
Source: International Congress 2017 – Best clinical practice for the management of chronic lung diseases
Year: 2017

Does physiotherapy affect Lung Clearance Index in Cystic Fibrosis patients ?
Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research
Year: 2018

What is a NICE definition of lung disease in patients with Cystic Fibrosis and its impact on treatment?
Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research
Year: 2018


Change of mucus rheology in patients with Cystic Fibrosis, COPD and Asthma
Source: International Congress 2018 – Biomarkers and lung function in airway disease
Year: 2018




Association between Pulmonary Infections and the Prognosis in Patients with Idiopathic Pulmonary Fibrosis
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021


LATE-BREAKING ABSTRACT: Efficacy of Pirfenidone for Idiopathic Pulmonary Fibrosis (IPF): an Italian real life study
Source: International Congress 2014 – IPF and surroundings
Year: 2014


Cognitive impairment and depression in patients with Idiopathic Pulmonary Fibrosis
Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias?
Year: 2018



Evaluation of Dyspnea Questionnaires in Patients with Idiopathic Pulmonary Fibrosis (IPF).
Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias
Year: 2018

Impact of Anemia On Clinically Stable Adult Non-cystic Fibrosis Bronchiectasis
Source: International Congress 2018 – Management of bronchiectasis and large airway diseases
Year: 2018


Impact of an interstitial lung diseases Nurse on the compliance to anti-fibrotic drugs in patients with Idiopathic Pulmonary Fibrosis.
Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF)
Year: 2018

The Effects Of Respiratory Viruses on The Acute Pulmonary Exacerbations In Cystic Fibrosis Patients
Source: International Congress 2019 – Insights into paediatric bronchology
Year: 2019


Cystic fibrosis and arthritis in children
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children
Year: 2013


Treatment of Idiopathic Pulmonary Fibrosis
Source: Guideline 2015
Year: 2015

Bacterial Contamination of Home Nebulizers in Children with Cystic Fibrosis and Clinical Implication on the Number of Pulmonary Exacerbations
Source: International Congress 2019 – Infection and inflammation in cystic fibrosis
Year: 2019


Comparison of the Cystic Fibrosis Questionnaire with the St George‘s Respiratory Questionnaire in adult patients with cystic fibrosis
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new aspects of risk factors, treatments and diagnosis
Year: 2012

Depression is a predominant symptom among hypogonadism male patients with Interstitial Pulmonary Fibrosis
Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias
Year: 2018

The European IPF Registry: Addressing challenges and characteristics of patients with Idiopathic Pulmonary Fibrosis
Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries
Year: 2018




Impact of specific organic exposure on the prognosis in Idiopathic Pulmonary Fibrosis
Source: International Congress 2017 – IPF: from the bench to the bedside
Year: 2017


Clinical Correlates of Physical Activity in Idiopathic Pulmonary Fibrosis (IPF)
Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases
Year: 2019

Adaptation of prevotella during acute infectious pulmonary exacerbation
Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology
Year: 2014